Kewaunee Scientific Corp
NASDAQ:KEQU
Relative Value
The Relative Value of one
KEQU
stock under the Base Case scenario is
79.91
USD.
Compared to the current market price of 41.75 USD,
Kewaunee Scientific Corp
is
Undervalued by 48%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
KEQU Competitors Multiples
Kewaunee Scientific Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Kewaunee Scientific Corp
NASDAQ:KEQU
|
119.7m USD | 0.4 | 10.2 | 6.4 | 8.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
197.6B USD | 4.4 | 30.2 | 17.3 | 23.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.1B USD | 17.5 | 61.7 | 46.9 | 57.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.6B USD | 5.8 | 45.2 | 22.8 | 27.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.3B USD | 3.5 | 26.9 | 14.6 | 21.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.5B USD | 5.5 | 37.8 | 22.1 | 29.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.4B EUR | 1.9 | 21.4 | 11.8 | 16.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.8B USD | 11.8 | 47.8 | 33.9 | 37.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.6B USD | 2.3 | 28.2 | 10.9 | 18.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.5B USD | 8.2 | 46.2 | 25.4 | 27.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.6B USD | 6.9 | 25.2 | 17.8 | 19.8 |